(2024). Mortality rate and acute kidney injury prevalence reduction in COVID‑19 critical patients treated with hemoperfusion.
Chicago Style (17th ed.) CitationMortality Rate and Acute Kidney Injury Prevalence Reduction in COVID‑19 Critical Patients Treated with Hemoperfusion. 2024.
MLA (8th ed.) CitationMortality Rate and Acute Kidney Injury Prevalence Reduction in COVID‑19 Critical Patients Treated with Hemoperfusion. 2024.
Warning: These citations may not always be 100% accurate.